-+ 0.00%
-+ 0.00%
-+ 0.00%

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga·03/26/2025 11:07:40
Listen to the news

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday.

Shares of Chewy, Inc. (NYSE:CHWY) fell sharply in pre-market trading ahead of quarterly earnings report.

Analysts expect the company to report quarterly earnings at 20 cents per share, up from 18 cents per share in the year-ago period. Chewy projects quarterly revenue of $3.2 billion, up from $2.83 billion a year earlier, according to data from Benzinga Pro.

Chewy shares declined 3.5% to $32.44 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Humacyte, Inc. (NASDAQ:HUMA) shares fell 22.1% to $2.24 in pre-market trading after the company priced its $50 million public offering of 25 million common stock at $2.00 per share.
  • Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) shares tumbled 14.6% to $7.00 in pre-market trading after gaining 41% on Tuesday.
  • Nyxoah S.A. (NASDAQ:NYXH) fell 11.8% to $9.99 in today's pre-market trading. The FDA issued Nyxoah an approvable letter for its Genio® system.
  • Rapport Therapeutics, Inc. (NASDAQ:RAPP) fell 9.5% to $9.10 in pre-market trading.
  • Oruka Therapeutics, Inc. (NASDAQ:ORKA) shares fell 5% to $11.40 in pre-market trading.
  • REGENXBIO Inc. (NASDAQ:RGNX) fell 3.8% to $7.90 in pre-market trading.
  • Rapport Therapeutics, Inc. (NASDAQ:RAPP) declined 3.5% to $9.70 in pre-market trading.
  • Perpetua Resources Corp. (NASDAQ:PPTA) fell 3% to $10.87 in pre-market trading.
  • Bausch Health Companies Inc. (NYSE:BHC) slipped 2.4% to $6.83 in pre-market trading. Bausch Health announced the pricing of upsized private offering of senior secured notes.

Now Read This: